West Family Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-500
Closed -$379K 92
2018
Q3
$379K Hold
500
0.09% 79
2018
Q2
$200K Buy
+500
New +$27K 0.05% 80
2016
Q3
Sell
-250
Closed -$304K 112
2016
Q2
$304K Buy
+250
New +$17.7K 0.06% 100

Other funds holding BMY

West Family Investments's BMY Position: Q2 2026 in Review

West Family Investments increased its Bristol-Myers Squibb (BMY) stake by 197% in Q2 2026, buying an estimated $398K and bringing the position to 10,464 shares worth $603K. The position accounts for 0.17% of the portfolio, ranked #139.

West Family Investments first reported a position in BMY in Q2 2021 and has held it in 18 quarters since. The position peaked at $882K in Q4 2022. 1,973 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • West Family Investments held 10,464 shares of Bristol-Myers Squibb worth $603K as of Q2 2026.
  • West Family Investments bought 6,936 Bristol-Myers Squibb shares in Q2 2026, an estimated $398K.
  • Bristol-Myers Squibb made up 0.17% of West Family Investments's portfolio in Q2 2026, its #139 holding.
  • West Family Investments first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 18 quarters since.
  • West Family Investments's Bristol-Myers Squibb position peaked at $882K in Q4 2022.
  • 1,973 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.